Sanofi SNY
NASDAQ SNY
$41.60 -0.36 (-0.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Sanofi (SNY) Net Income (2009 - 2026)

Updated

Sanofi (SNY) reported Net Income of $438.21 million for the quarter ended Jun 30, 2026, down 94.0% from $7.31 billion a year earlier and down 76.9% from the prior quarter.

Analysis

Sanofi (SNY) Net Income (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Sanofi's Net Income came in at $2.37 billion, down 81.7% year-over-year; for the year ended Dec 31, 2025, it was $8.87 billion, up 45.9% from the prior year.

  • Net Income has a five-year compound annual growth rate of -8.8% (years ended Dec 2020 to Dec 2025).
  • By year, Net Income came in at $6.08 billion in the year ended Dec 31, 2024 (+3.4%), $5.88 billion in the year ended Dec 31, 2023 (-34.2%), $8.94 billion in the year ended Dec 31, 2022 (+20.3%) and $7.43 billion in the year ended Dec 31, 2021 (-47.2%).
  • Five-year quarterly Net Income spans a low of -$10.07 billion in the quarter ended Dec 31, 2025 and a high of $10.11 billion in the quarter ended Sep 30, 2025.
  • Year over year, Net Income gained in three of the last seven quarters, with growth averaging 80.8%.
  • The high point for year-over-year Net Income in five years was the quarter ended Jun 30, 2025 (growth of 507.7%); the low point was the quarter ended Dec 31, 2024 (a decline of 94.4%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $1.9 billion (quarter ended Mar 31, 2026), -$10.07 billion (quarter ended Dec 31, 2025) and $10.11 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 210.00 Mn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 3.62 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 2.51 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.50 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -248.00 Mn
10 Sanofi 50.74 Bn 17.26 Bn 10.79 Bn 438.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 438.21 Mn
Mar 31, 2026 1.90 Bn
Dec 31, 2025 -7.72 Bn
Sep 30, 2025 10.11 Bn
Jun 30, 2025 4.46 Bn
Mar 31, 2025 1.99 Bn
Dec 31, 2024 546.05 Mn
Sep 30, 2024 3.12 Bn
Jun 30, 2024 1.20 Bn
Mar 31, 2024 1.24 Bn
Dec 31, 2023 -600.37 Mn
Sep 30, 2023 2.76 Bn
Jun 30, 2023 1.58 Bn
Mar 31, 2023 2.16 Bn
Dec 31, 2022 3.23 Bn
Sep 30, 2022 2.10 Bn
Jun 30, 2022 1.30 Bn
Mar 31, 2022 2.26 Bn
Dec 31, 2021 1.31 Bn
Sep 30, 2021 2.75 Bn
API Access

Sanofi Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=SNY&period=max&api_key=YOUR_API_KEY